Yokohama, Japan

Kazuhiro Aihara


Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • Kanagawa-ken, JP (1999 - 2009)
  • Yokohama, JP (2001 - 2013)

Company Filing History:


Years Active: 1999-2013

Loading Chart...
12 patents (USPTO):

Title: Unveiling the Inventive Journey of Kazuhiro Aihara

Introduction: Kazuhiro Aihara, a prolific inventor based in Yokohama, JP, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 12 patents. His latest patents showcase his prowess in developing 2-thioethenyl substituted carbapenem derivatives, demonstrating potent antimicrobial activity against a spectrum of resistant bacteria.

Latest Patents: Aihara's recent patents focus on 2-thioethenyl substituted carbapenem derivatives, specifically targeting pneumococci strains such as penicillin-resistant (PRSP) and beta-lactamase-negative, ampicillin-resistant (BLNAR). These innovative compounds aim to address clinical challenges posed by antibiotic-resistant bacteria, offering promising solutions in the realm of antimicrobial therapy.

Career Highlights: Throughout his career, Kazuhiro Aihara has been associated with renowned companies such as Meiji Seika Kaisha, Ltd., and Meiji Seika Kabushiki Kaisha. His innovative mindset and dedication to advancing pharmaceutical research have propelled him to the forefront of the industry, establishing him as a key figure in the realm of drug discovery and development.

Collaborations: Aihara has collaborated closely with esteemed colleagues in his field, including Kunio Atsumi and Yuko Kano. Together, they have fostered a culture of innovation and scientific excellence, driving forward groundbreaking research initiatives and pioneering new avenues in pharmaceutical development.

Conclusion: In conclusion, Kazuhiro Aihara stands as a shining example of inventive brilliance in the realm of pharmaceutical innovation. His pioneering work in the development of antimicrobial compounds underscores his commitment to addressing critical healthcare challenges and shaping the future of medicine. Aihara's steadfast dedication to innovation continues to inspire and redefine the landscape of pharmaceutical research, leaving a lasting impact on the industry as a whole.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…